iifl-logo

Orient Tradelink Ltd Board Meeting

20.26
(-3.80%)
Nov 28, 2025|12:00:00 AM

Orient Tradelink CORPORATE ACTIONS

29/11/2024calendar-icon
29/11/2025calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting26 Nov 202526 Nov 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Wednesday, 26th November 2025 inter-alia considered & approved the following items: Allotment of 1,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting24 Nov 202531 Oct 2025
Orient Tradelink Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve this is to inform you that the meeting of the Board of Directors of Orient Tradelink Limited is scheduled to be held on Friday, 14th November, 2025, at the Corporate Office of the Company situated at 141-A Ground Floor, Shahpur Jat Village New Delhi- 110049 inter alia, to consider and approve the following matter(s): 1. To consider, approve and take on record the Unaudited Standalone Financial Results of the Company along with Limited Review Report for the Quarter and half year ended 30th September, 2025. 2. To consider any other matter with the permission of the Chair as the Board may think fit. The Board Meeting to be held on 14/11/2025 has been revised to 19/11/2025 The Board Meeting to be held on 14/11/2025 has been revised to 19/11/2025. (As Per Bse Announcement dated on 13/11/2025) We wish to inform you that due to non availability of Directors, the meeting of the Board of Directors which was scheduled to be held on Wednesday, 19th November 2025 stands postponed. The Board Meeting will now be held on Friday, 21st November 2025 at the Corporate Office of the Company (As per BSE Announcement dated on: 19.11.2025) Orient Tradelink Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/11/2025 ,inter alia, to consider and approve 1. To consider, approve and take on record the Unaudited Standalone Financial Results of the Company along with the Limited Review Report for the Quarter and Half Year ended 30th September 2025. 2. To consider any other matter with the permission of the Chair, as the Board may think fit. (As per BSE Announcement dated on: 21.11.2025) The Board of Directors of Orient Tradelink Limited at their meeting held on Monday, 24th November, 2025, at the corporate office of the Company situated at 141-A Ground Floor, Shahpur Jat Village New Delhi- 110049 has inter alia, considered & approved the following items:- 1.The Standalone Un-audited Financial Results of the Company for the Quarter and half year ended 30th September, 2025. 2. Allotment of 2,00,000 Equity shares upon exercise of option for conversion of warrants into equal number of Equity Shares . (As Per BSE Announcement Dated on:24.11.2025)
Board Meeting20 Nov 202520 Nov 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, 20th November 2025 inter-alia considered & approved the following items: Allotment of 2,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares . we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, 20th November 2025 inter-alia considered & approved the following items: Allotment of 2,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares we would like to inform you that the Board of Directors of the Company in their meeting held on Friday, 14th November 2025 inter-alia considered & approved the following items: Allotment of 3,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting14 Nov 202514 Nov 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Friday, 14th November 2025 inter-alia considered & approved the following items: Allotment of 3,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares .
Board Meeting10 Nov 202510 Nov 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Monday, 10th November 2025 inter-alia considered & approved the following items: Allotment of 4,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting29 Oct 202529 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Wednesday, 29th October 2025 inter-alia considered & approved the following items: Allotment of 28,24,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting25 Oct 202525 Oct 2025
As per Regulation 30 and any other applicable Regulations, if any, of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors of the Company in their meeting held on Saturday, 25th October 2025 inter-alia considered & approved the following items:
Board Meeting24 Oct 202524 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Friday, 24th October 2025 inter-alia considered & approved the following items: Allotment of 10,32,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting23 Oct 202523 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, 23rd October 2025 inter-alia considered & approved the following items: Allotment of 29,54,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting17 Oct 202517 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Friday, 17th October 2025 inter-alia considered & approved the following items: Allotment of 20,05,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting16 Oct 202516 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, 16th October 2025 inter-alia considered & approved the following items: Allotment of 28,22,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares . we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, 16th October 2025 inter-alia considered & approved the following items: Allotment of 28,22,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares .
Board Meeting15 Oct 202515 Oct 2025
Outcome of Board Meeting under Regulation 30 of SEBI (LODR) Regulations. 2015 on Allotment of 11,42,000 Equity shares upon Conversion of Warrant into Equity Shares As per Regulation 30 and any other applicable Regulations, if any, of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015 we would like to inform you that the Board of Directors of the Company in their meeting held on Wednesday, 15th October 2025 inter-alia considered & approved the following items:
Board Meeting14 Oct 202514 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Tuesday, 14th October 2025 inter-alia considered & approved the following items: Allotment of 1,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares.
Board Meeting13 Oct 202513 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Monday, 13th October 2025 inter-alia considered & approved the following items: Allotment of 8,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting9 Oct 20259 Oct 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Thursday, 09th October 2025 inter-alia considered & approved the following items: 1. Allotment of 5,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting24 Sep 202524 Sep 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Wednesday, 24th September 2025 inter-alia considered & approved the following items: Allotment of 8,90,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting15 Sep 202515 Sep 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Monday, 15th September 2025 inter-alia considered & approved the following items: 1. Allotment of 100000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares.
Board Meeting12 Sep 202512 Sep 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Friday, 12th September 2025 inter-alia considered & approved the following items: 1. Allotment of 6,98,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting10 Sep 202510 Sep 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Wednesday, 10th September 2025 inter-alia considered & approved the following items: 1. Allotment of 12,50,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants
Board Meeting9 Sep 20259 Sep 2025
we would like to inform you that the Board of Directors of the Company in their meeting held on Tuesday, 9th September 2025 inter-alia considered & approved the following items: 1. Allotment of 2,00,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares
Board Meeting6 Sep 20252 Sep 2025
Inter alia, to consider and approve:- 1.Raising of funds by way of issuance of equity shares or any other eligible securities (Securities) through permissible modes, including but not limited to a private placement,right issue, a qualified institutions placement, preferential issue, or any other method or combination of methods as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required and the approval of shareholders of the Company. 2. Convening of a Shareholders Meeting (General Meeting / Postal Ballot), to seek approval of the shareholders for fund-raising. Meeting held on Saturday, 06th September, 2025 at the Corporate office of the Company situated at141-A Ground Floor, ShahpurJat Village, New Delhi, India, 110049, considered and approved the matter as stated in the outcome (As per BSE Announcement Dated on 06/09/2025)
Board Meeting1 Sep 20251 Sep 2025
The Board of Directors of the Company in their meeting held on Monday, 01st September 2025 inter-alia considered & approved the following items: Allotment of 100000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares against receipt of balance subscription amount of 75% (INR 12/- Per Warrant) of warrant issue price.
Board Meeting30 Aug 202530 Aug 2025
Board of Directors of the Company In their meeting held on Saturday, 30th August 2025 inter-alia considered & approved the following items: Allotment of 100000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share,
Board Meeting29 Aug 202529 Aug 2025
The Board of Directors of the Company in their meeting held on Friday, 29th August 2025 inter-alia considered & approved the following items: 1. Allotment of 100000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares against receipt of balance subscription amount of 75% (INR 12/- Per Warrant) of warrant issue price in accordance with the provisions of Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
Board Meeting14 Aug 20255 Aug 2025
Orient Tradelink Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 inter alia to consider and approve 1. The Unaudited Standalone Financial Results of the Company along with Limited Review Report for the Quarter ended 30th June 2025. 2. Any other matter with the permission of the Chair as the Board may think fit. Allotment of 100000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares against receipt of balance subscription amount of 75% (INR 12/- Per Warrant) of warrant (As Per BSE Announcement Dated on:12.08.2025) Pursuant to Regulation 30 and 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of Orient Tradelink Limited at their meeting held on Thursday, 14th August, 2025, at the corporate office of the Company situated at 141-A Ground Floor, Shahpur Jat Village New Delhi, Delhi - 110049 has inter alia, considered and approved the Standalone Un-audited Financial Results of the Company for the Quarter ended 30th June, 2025. (As Per BSE Announcement Dated on: 14.08.2025)
Board Meeting13 Aug 202513 Aug 2025
The Board of Directors of the Company in their meeting held on Wednesday, 13th August 2025 inter-alia considered & approved the following items: 1. Allotment of 200000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of warrants into equal number of Equity Shares against receipt of balance subscription amount of 75% (INR 12/- Per Warrant) of warrant issue price in accordance with the provisions of Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
Board Meeting30 Jul 202530 Jul 2025
This is to inform you that the Board of Directors of the Company at their meeting held on Wednesday, 30th July, 2025, (Commenced from 04:00 PM and concluded at 04:30 P.M) at the corporate office situated at 141-A Ground Floor, Shahpur Jat Village New Delhi-110049, has inter alia considered and approved the change in name of the Company from Orient Tradelink Limited to Radiant Ventures Limited or any other name as maybe available with Ministry of Corporate Affairs, subject to inter-alia securing approval of shareholders in the ensuing General Meeting and such other applicable statutory/regulatory authorities.
Board Meeting20 Jun 202520 Jun 2025
Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of Orient Tradelink Limited (the Company) at their meeting held on Friday, 20th June, 2025 at the Corporate Office of the Company at 141- A Ground Floor, Shahpur Jat Village New Delhi, Delhi - 110049, India, has considered and approved the following matter: Appointment of Ms. Priya (Membership Number: A77022) as a Company Secretary & Compliance Officer of the Company w.e.f. 20.06.2025. (Annexure-A)
Board Meeting29 May 202521 May 2025
Orient Tradelink Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 inter alia to consider and approve 1. To consider approve and take on record the (Standalone) Audited Financial Results of the Company for the Quarter and Financial Year ended on 31st March 2025. 2. To consider any other matter with the permission of the Chair as the Board may think fit or which is incidental and ancillary to the business of the Company. Pursuant to Regulation 30 and 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, this is to inform you that the Board of Directors of Orient Tradelink Limited at their meeting held on Thursday, 29th May, 2025 at the Corporate Office of the Company at 141-A Ground Floor, Shahpur Jat Village New Delhi, Delhi - 110049, India, has inter alia, considered and approved the following matter(s): 1. The Annual Audited Standalone Financial Results of the Company for the quarter and financial year ended on 31st March, 2025. 2. Considered and taken on record of the resignation of Dr. Balakrishna Ramarao Maddur, from the post of Independent Director of the Company. 3. Considered and taken on record of the resignation of Mr. Akash Toshniwal from the post of Company Secretary and Compliance Officer (Key Managerial Personnel) of the Company. (As per BSE Announcement Dated on 29/05/2025)
Board Meeting17 May 202517 May 2025
Allotment of 24,50,000 Equity shares of INR 10/- each at a price of INR 16/- per share comprising of premium of INR 6/- each per share, upon exercise of option for conversion of equity warrants into equal number of Equity Shares against receipt of balance subscription amount of 75% (INR 12/- Per Warrant) of warrant issue price in accordance with the provisions of Chapter V of the SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018 and in terms of In - Principle Approval received from BSE Limited (BSE) on 1st April 2025.
Board Meeting18 Apr 202518 Apr 2025
Outcome of Board meeting held today for Allotment of 900000 Equity Shares to Non Promoters pursuant to Conversion of Warrants Into Equity Shares
Board Meeting15 Apr 202515 Apr 2025
This to inform to all Stakeholders that Board Of directors in their meeting held today has alloted 3942000 Convertible Warrants To Non Promoters pursuant to preferential issue This is to inform all the stakeholders that Board of Directors has conducted Board Meeting at 1.00 pm which was concluded at 1.50 pm , and duly adjourned and re convened at 5.30pm and concluded at 7.30 pm for Allotment of 5142000 Convertible warrants to Non Promoters on Preferential Basis
Board Meeting14 Apr 202514 Apr 2025
This to inform to all the Stakeholders that board of directors in their meeting held today on 14 april 2025 alloted 875000 convertible warrants to non promoters on preferential basis pursuant to in-principle approval received on 1st april 2025.
Board Meeting11 Apr 202511 Apr 2025
This is to inform all the stakeholders that Board of Directors in their meeting held today has allotted 2100000 convertible warrants to Non Promoters pursuant to Preferential Issue subject to Inprinciple Approval Received on 1st April,2025
Board Meeting10 Apr 202510 Apr 2025
This is to inform all the stakeholders that Board of Directors in their meeting held today has allotted 1940000 Convertible Warrants to Non Promoters on Preferential Basis pursuant to In-principle Approval letter received on 1st April, 2025 from BSE India
Board Meeting9 Apr 20259 Apr 2025
This is to inform all the stakeholders that Board of Directors in their meeting held today has Allotted 43,05,000 Convertible Warrants to Non Promoters pursuant to Preferential Issue subject to Inprinciple Approval received on 1st April, 2025.
Board Meeting8 Apr 20258 Apr 2025
This is to inform you that Board of Directors in their meeting held today has allotted 5565000 Convertible warrants at issue price Rs 16 pursuant to Preferential Issue and subject to In-principle Approval received on 1st April, 2025 from BSE India
Board Meeting7 Apr 20257 Apr 2025
This is to inform all stakeholders that Board of Directors in their meeting held today has allotted 43,30,000 Convertible warrants to Non Promoters pursuant to Preferential Issue subject to In-principle Approval letter received from BSE INDIA dated 1st April,2025
Board Meeting5 Apr 20255 Apr 2025
This is to inform all the Stakeholders that Board of Directors in their Meeting held today has allotted 56,55,000 convertible warrants to Non Promoters at the issue price of Rs 16/-
Board Meeting4 Apr 20254 Apr 2025
This is to inform all the Stakeholders that Board of Directors in their Meeting held today has allotted 21,00,000 convertible warrants to Non Promoters at the issue price of RS 16/-
Board Meeting29 Mar 202529 Mar 2025
With references to the above captioned subject outcome for Board Meeting held for appointment for Internal Auditor and Secretarial Auditor.
Board Meeting11 Feb 20253 Feb 2025
ORIENT TRADELINK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve The Standalone Unaudited Financial Results of The Company for the Quarter Ended December 31 2024 and to consider any other items. Outcome Of The Board For The Approval Of The Standalone Unaudited Financial Results Of The Company For The Quarter Ended On 31St December, 2024. Board has approved Quarterly results for the period ended 31st December, 2024 (As Per BSE Announcement dated on 11.02.2025)

Orient Tradelink: Related News

No Record Found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.